1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Contraceptives-Pipeline Insights, 2017

Contraceptives-Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight


DelveInsight’s, “ Contraceptives-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Contraceptives. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Contraceptives. DelveInsight’s Report also assesses the Contraceptives therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Contraceptives
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Contraceptives pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Contraceptives and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Contraceptives-Pipeline Insights, 2017
Illustrative

- Contraceptives Overview
- Contraceptives Pipeline Therapeutics
- Contraceptives Therapeutics under Development by Companies
- Contraceptives Filed and Phase III Products
- Comparative Analysis
- Contraceptives Phase II Products
- Comparative Analysis
- Contraceptives Phase I and IND Filed Products
- Comparative Analysis
- Contraceptives Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Contraceptives - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Contraceptives - Discontinued Products
- Contraceptives - Dormant Products
- Companies Involved in Therapeutics Development for Contraceptives
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Contraceptives, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Contraceptives Assessment by Monotherapy Products
- Contraceptives Assessment by Combination Products
- Contraceptives Assessment by Route of Administration
- Contraceptives Assessment by Stage and Route of Administration
- Contraceptives Assessment by Molecule Type
- Contraceptives Assessment by Stage and Molecule Type
- Contraceptives Therapeutics - Discontinued Products
- Contraceptives Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Contraceptives, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Contraceptives Assessment by Monotherapy Products
- Contraceptives Assessment by Combination Products
- Contraceptives Assessment by Route of Administration
- Contraceptives Assessment by Stage and Route of Administration
- Contraceptives Assessment by Molecule Type
- Contraceptives Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Contraceptives - Consumer Healthcare

Global Contraceptives - Consumer Healthcare

  • $ 4950
  • Industry report
  • January 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Contraceptives in US$ by the following Contraception Methods: Hormonal Contraceptives (Oral Contraceptives, & Other Hormonal Contraceptives), and Condoms. ...

Global Intrauterine Contraceptive Devices Market - Growth, Trends and Forecasts (2017 - 2022)

Global Intrauterine Contraceptive Devices Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4750
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The Global Intra Uterine contraceptive Devices market is estimated to be USD 1,370 million in 2016 and is expected to reach USD 2,267 million by 2021, growing at a compound annual growth rate (CAGR) of ...

Global Contraceptive Pills Market - Growth, Trends and Forecasts (2017 - 2022)

Global Contraceptive Pills Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global market for contraceptive pills is estimated to be USD 680 million in the year 2014. This market is expected to reach USD 1.03 billion by the end of 2019. During this period, the market is estimated ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • March 2017
    265 pages
  • Therapy  

    Cardiovascular ...  

    Risky Behaviour  

  • United States  

View report >

Therapy Market in the US

  • March 2017
  • Therapy  

  • United States  

View report >

Emergency Contraception Market in the US

  • March 2017
    5 pages
  • Emergency Contr...  

  • United States  

View report >

Related Market Segments :

Contraceptive

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.